ProKidney appoints Dr. Bruce Culleton as executive VP of clinical development and commercialization

Dr. Culleton brings over two decades of industry and academic experience in kidney health to ProKidney, a public biotech company that is working to advance its regenerative medicine therapy through multiple clinical trials.